Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ICU MEDICAL INC/DEICUI · Entity 2385 | Chief Financial Officer, | February 14, 2020 | February 14, 2020 |
| Pennant Group, Inc.PNTG · Entity 4774 | Director | July 15, 2026 | July 17, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ICU MEDICAL INC/DE
Report date February 14, 2020 · Filed February 14, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 16,274 |
Ending reported balance
After 2020-02-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2020-02-14 · Exercise / conversion · Acquired 1,006 · Balance 16,803 Row 2 · 2020-02-14 · Tax withholding · Disposed 529 · Balance 16,274 |
| Performance SharesSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2021-02-15 | Direct | 1,005 |
Reported balance
After 2020-02-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-02-14 · Exercise / conversion · Disposed 1,006 · Balance 1,005 F1: These Securities are Performance-based Restricted Stock Units (PRSU). F2: There is neither a purchase price nor an exercise price for the PRSUs. F3: These PRSUs were granted on March 6, 2018. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on February 15 of the first, second, and third year following the year of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: These Securities are Performance-based Restricted Stock Units (PRSU).
F2: There is neither a purchase price nor an exercise price for the PRSUs.
F3: These PRSUs were granted on March 6, 2018. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on February 15 of the first, second, and third year following the year of grant.
Pennant Group, Inc.
Report date July 15, 2026 · Filed July 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 58,935 |
Reported balance
After 2026-07-15 transaction · row 1
1 source rowRow 1 · 2026-07-15 · Grant · Acquired 2,400 · Balance 58,935 F1: These shares vest in three annual installments beginning July 15, 2027. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares vest in three annual installments beginning July 15, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 15, 2026 Filed Jul 17, 2026 18:46 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-26-000002 · wk-form4_1784313993.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,935 F1 · shares: These shares vest in three annual installments beginning July 15, 2027. Read SEC document |
| April 15, 2026 Filed Apr 17, 2026 23:02 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-26-000047 · wk-form4_1776466938.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 56,535 F1 · shares: These shares vest in three annual installments beginning April 15, 2027. Read SEC document |
| January 15, 2026 Filed Jan 21, 2026 18:46 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-26-000007 · wk-form4_1769021173.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,135 F1 · shares: These shares vest in three annual installments beginning January 15, 2027. Read SEC document |
| October 15, 2025 Filed Oct 16, 2025 21:11 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-25-000129 · wk-form4_1760649087.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,735 F1 · shares: These shares vest in three annual installments beginning October 15, 2026. Read SEC document |
| July 15, 2025 Filed Jul 17, 2025 20:16 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-25-000089 · wk-form4_1752783360.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 49,335 F1 · shares: These shares vest in three annual installments beginning July 15, 2026. Read SEC document |
| April 15, 2025 Filed Apr 17, 2025 21:38 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-25-000046 · wk-form4_1744925883.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,935 F1 · shares: These shares vest in three annual installments beginning April 15, 2026. Read SEC document |
| January 15, 2025 Filed Jan 16, 2025 22:55 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 2,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-25-000016 · wk-form4_1737068137.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,535 F1 · shares: These shares vest in three annual installments beginning January 15, 2026. Read SEC document |
| October 15, 2024 Filed Oct 17, 2024 21:06 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-24-000115 · wk-form4_1729199156.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,135 F1 · shares: These shares vest in three annual installments beginning October 15, 2025. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 22:53 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 3,000 | $26.25 | $78,750.00 |
DisclosureSEC source: 0001766400-24-000080 · wk-form4_1721256803.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,135 F1 · shares: These shares vest in three annual installments beginning July 15, 2025. Read SEC document |
| April 15, 2024 Filed Apr 17, 2024 22:38 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-24-000049 · wk-form4_1713393475.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,135 F1 · shares: These shares vest in three annual installments beginning April 15, 2025. Read SEC document |
| January 16, 2024 Filed Jan 18, 2024 23:52 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-24-000012 · wk-form4_1705621951.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,135 F1 · shares: These shares vest in three annual installments beginning January 16, 2025. Read SEC document |
| October 16, 2023 Filed Oct 18, 2023 23:00 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-23-000113 · wk-form4_1697669998.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,135 F1 · shares: These shares vest in three annual installments beginning October 16, 2024. Read SEC document |
| July 17, 2023 Filed Jul 19, 2023 22:42 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-23-000083 · wk-form4_1689806528.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,635 F1 · shares: These shares vest in three annual installments beginning July 17, 2024. Read SEC document |
| April 18, 2023 Filed Apr 19, 2023 23:14 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 1,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-23-000054 · wf-form4_168194605072058.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,135 F1 · shares: These shares vest in three annual installments beginning April 17, 2024. Read SEC document |
| January 17, 2023 Filed Jan 20, 2023 00:05 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-23-000012 · wf-form4_167417308182001.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,635 F1 · shares: These shares vest in three annual installments beginning January 17, 2024. Read SEC document |
| October 17, 2022 Filed Oct 19, 2022 22:48 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-22-000138 · wf-form4_166621966755091.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,135 F1 · shares: These shares vest in three annual installments beginning October 17, 2023. Read SEC document |
| July 15, 2022 Filed Jul 19, 2022 22:54 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-22-000098 · wf-form4_165827125065783.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,385 F1 · shares: These shares vest in three annual installments beginning July 15, 2023. Read SEC document |
| April 18, 2022 Filed Apr 20, 2022 23:06 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-22-000059 · wf-form4_165049596080900.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,635 F1 · shares: These shares vest in three annual installments beginning April 18, 2023. Read SEC document |
| January 18, 2022 Filed Jan 20, 2022 22:01 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-22-000013 · wf-form4_164271604405499.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,885 F1 · shares: These shares vest in three annual installments beginning January 18, 2023. Read SEC document |
| October 15, 2021 Filed Oct 19, 2021 23:31 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-21-000142 · wf-form4_163468627785104.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,135 F1 · shares: These shares vest in three annual installments beginning October 15, 2022. Read SEC document |
| July 15, 2021 Filed Jul 19, 2021 23:16 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-21-000097 · wf-form4_162673660600321.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,385 F1 · shares: These shares vest in three annual installments beginning July 15, 2022. Read SEC document |
| April 15, 2021 Filed Apr 19, 2021 22:41 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-21-000059 · wf-form4_161887207243832.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,635 F1 · shares: These shares vest in three annual installments beginning April 15, 2022. Read SEC document |
| January 15, 2021 Filed Jan 21, 2021 00:08 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 750 | $57.54 | $43,155.00 |
DisclosureSEC source: 0001766400-21-000017 · wf-form4_161118772375430.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,885 F1 · shares: These shares vest in three annual installments beginning January 15, 2022. Read SEC document |
| October 15, 2020 Filed Oct 19, 2020 22:49 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-20-000116 · wf-form4_160314776686639.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,135 F1 · shares: These shares vest in three annual installments beginning October 15, 2021. Read SEC document |
| July 15, 2020 Filed Jul 17, 2020 22:19 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-20-000083 · wf-form4_159502437828916.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,385 F1 · shares: These shares vest in three annual installments beginning July 15, 2021. Read SEC document |
| April 15, 2020 Filed Apr 17, 2020 22:57 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-20-000048 · wf-form4_158716423883205.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,635 F1 · shares: These shares vest in three annual installments beginning April 15, 2021. Read SEC document |
| March 13, 2020 Filed Mar 17, 2020 22:03 UTC | Pennant Group, Inc. PNTG · Entity 4774 | PurchaseCommon Stock | 6,300 | $15.62 | $98,406.00 |
DisclosureSEC source: 0001766400-20-000038 · wf-form4_158448260058510.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,885 Read SEC document |
| February 14, 2020 Filed Feb 14, 2020 23:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionPerformance Shares · Derivative | 1,006 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001375852-20-000004 · edgardoc.xml · derivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005 Underlying: Common Stock · 1,006 shares Expires 2021-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F3 · derivative.exercise_date: These PRSUs were granted on March 6, 2018. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on February 15 of the first, second, and third year following the year of grant. Read SEC document |
| February 14, 2020 Filed Feb 14, 2020 23:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 529 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-20-000004 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,274 Read SEC document |
| February 14, 2020 Filed Feb 14, 2020 23:56 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 1,006 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-20-000004 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 18:46 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock · Derivative | 1,778 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001375852-20-000002 · edgardoc.xml · derivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,334 shares Expires 2019-12-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: These Securities are Performance-based Restricted Stock Units (PRSU). F2 · derivative.exercise_price: There is neither a purchase price nor an exercise price for the PRSUs. F3 · shares: Each PRSU reflects the contingent right to receive a variable number of shares of common stock based on achieving performance goals. At the determination date, based on certification of the achievement of the performance criteria, the reporting person earned 300% of the target award amount. F4 · derivative.exercise_date: These PRSUs were granted on March 27, 2017. The vesting for this performance-based restricted stock unit ("PRSU") award was dependent upon the achievement of a minimum Cumulative Adjusted EBITDA over the Fiscal Years 2017-2019. The reporting person was able to earn PRSUs ranging from 100% to 300% of the target award amount. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 18:46 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Tax withholdingCommon Stock | 2,846 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-20-000002 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,797 Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 18:46 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | Exercise / conversionCommon Stock | 5,334 | $0.00 | $0.00 |
DisclosureSEC source: 0001375852-20-000002 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,643 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2020 Filed Jan 17, 2020 23:26 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-20-000013 · wf-form4_157930356217499.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,585 F1 · shares: These shares vest in three annual installments beginning January 15, 2021. Read SEC document |
| December 10, 2019 Filed Dec 10, 2019 22:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 20,815 | $58.79 Strike: $58.79 | $1,223,713.85 |
DisclosureSEC source: 0001375852-19-000011 · edgardoc.xml · derivative · entry 10 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 20,815 shares Expires 2024-02-24 F7 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| December 10, 2019 Filed Dec 10, 2019 22:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 173 | $179.19 | $30,999.14 |
DisclosureSEC source: 0001375852-19-000011 · edgardoc.xml · nonDerivative · entry 8 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,309 F6 · price: he price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $179.18 to $179.19, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 10, 2019 Filed Dec 10, 2019 22:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 15,904 | $178.14 | $2,833,140.15 |
DisclosureSEC source: 0001375852-19-000011 · edgardoc.xml · nonDerivative · entry 7 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,482 F5 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $178.00 to $178.65, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 10, 2019 Filed Dec 10, 2019 22:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 4,738 | $177.22 | $839,674.52 |
DisclosureSEC source: 0001375852-19-000011 · edgardoc.xml · nonDerivative · entry 6 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,386 F4 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $177.00 to $177.90, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 10, 2019 Filed Dec 10, 2019 22:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 20,815 | $58.79 | $1,223,713.85 |
DisclosureSEC source: 0001375852-19-000011 · edgardoc.xml · nonDerivative · entry 5 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,124 Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 22:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 9,185 | $58.79 Strike: $58.79 | $539,986.15 |
DisclosureSEC source: 0001375852-19-000011 · edgardoc.xml · derivative · entry 9 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,815 Underlying: Common Stock · 9,185 shares Expires 2024-02-24 F7 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 22:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 11 | $184.00 | $2,024.00 |
DisclosureSEC source: 0001375852-19-000011 · edgardoc.xml · nonDerivative · entry 4 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,309 F3 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 22:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 41 | $181.09 | $7,424.62 |
DisclosureSEC source: 0001375852-19-000011 · edgardoc.xml · nonDerivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,320 F2 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $181.00 to $181.15, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 22:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 9,133 | $180.57 | $1,649,150.38 |
DisclosureSEC source: 0001375852-19-000011 · edgardoc.xml · nonDerivative · entry 2 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,361 F1 · price: The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $180.00 to $180.98, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| December 09, 2019 Filed Dec 10, 2019 22:29 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 9,185 | $58.79 | $539,986.15 |
DisclosureSEC source: 0001375852-19-000011 · edgardoc.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,494 Read SEC document |
| November 18, 2019 Filed Nov 20, 2019 23:06 UTC | Pennant Group, Inc. PNTG · Entity 4774 | PurchaseCommon Stock | 5,085 | $20.20 | $102,728.70 |
DisclosureSEC source: 0001766400-19-000035 · wf-form4_157429120189909.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,835 F1 · price: This transaction was executed in multiple trades at prices ranging from $20.09 to $20.21. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request by the commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares executed at each separate price. Read SEC document |
| October 15, 2019 Filed Oct 17, 2019 22:20 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantCommon Stock | 750 | $0.00 | $0.00 |
DisclosureSEC source: 0001766400-19-000016 · wf-form4_157135078915747.xml · nonDerivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 750 F1 · shares: These shares vest in three annual installments beginning October 15, 2020. Read SEC document |
| October 01, 2019 Filed Oct 4, 2019 00:25 UTC | Pennant Group, Inc. PNTG · Entity 4774 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $15.09 | $0.00 |
DisclosureSEC source: 0000899243-19-025007 · doc4.xml · derivative · entry 1 Lamb Scott E · CIK 0001375852 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2029-10-01 F1 · derivative.exercise_date: Options granted on October 1, 2019 under The Pennant Group, Inc. 2019 Omnibus Incentive Plan. The options vest in three equal annual installments beginning on the first anniversary of the date of the grant. Read SEC document |
| June 26, 2019 Filed Jun 26, 2019 21:37 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherNon-Qualified Stock Option (right to buy) · Derivative | 3,325 | $58.79 Strike: $58.79 | $195,476.75 |
DisclosureSEC source: 0001375852-19-000009 · edgardoc.xml · derivative · entry 6 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 3,325 shares Expires 2024-02-24 F4 · price: Transaction is the exercise of a derivative security; see Column 2. F3 · derivative.exercise_date: Twenty-five percent of the shares shall vest on each of the first, second,third, and fourth anniversaries of the grant date . Fifty percent of the vested shares shall become exercisable if, during the term of the option, the closing price of the Company's common stock is equal to or more than one-hundred and twenty-five percent of the exercise price per share for thirty consecutive trading days. The remaining fifty percent of the vested shares shall become exercisable if, after the date of award and on or before the expiration date, the closing price of the Company's common stock is equal to or more than one-hundred and fifty percent of eh exercise price for 30 consecutive trading days. Read SEC document |
| June 26, 2019 Filed Jun 26, 2019 21:37 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | SaleCommon Stock | 3,325 | $250.00 | $831,250.00 |
DisclosureSEC source: 0001375852-19-000009 · edgardoc.xml · nonDerivative · entry 4 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,309 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 11, 2019. F2 · price: All shares sold were sold at the exact price disclosed. Read SEC document |
| June 26, 2019 Filed Jun 26, 2019 21:37 UTC | ICU MEDICAL INC/DE ICUI · Entity 2385 | OtherCommon Stock | 3,325 | $58.79 | $195,476.75 |
DisclosureSEC source: 0001375852-19-000009 · edgardoc.xml · nonDerivative · entry 3 Lamb Scott E · CIK 0001375852 · Chief Financial Officer, 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,634 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.